MeSH D001228 - aspergillosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Amphotericin b | Amphotericin B | 1995-03-31 | |||
| Miconazole | Miconazole | 1992-10-30 | ||||
| Voriconazole | Voriconazole | 2012-04-06 | ||||
| Taro Pharmaceutical | Miconazole | Miconazole | 1997-01-13 | |||
| Glenmark Pharmaceuticals | Voriconazole | Voriconazole | 2015-09-02 | |||
| Mylan | Caspofungin | Caspofungin | 2017-09-29 | |||
| Itraconazole | Itraconazole | 2012-07-20 | ||||
| Voriconazole | Voriconazole | 2010-04-22 | ||||
| Miconazole, White petrolatum | Vusion | 2028-03-30 | 2006-02-16 | |||
| Mayne Group | Itraconazole | Tolsura | 2023-07-25 | 2018-12-11 | ||
| Johnson & Johnson | Miconazole | Monistat | 1982-01-01 | |||
| Itraconazole | Sporanox | 1992-09-11 | ||||
| Perrigo | Miconazole | Miconazole | 1997-03-20 | |||
| Cosette Pharmaceuticals | Miconazole | M-zole | 1999-04-16 | |||
| Miconazole | Miconazole | 1993-11-19 | ||||
| P&L Developments (PLD) | Miconazole | Miconazole | 1996-03-29 | |||
| Cipla | Caspofungin | Caspofungin | 2018-07-12 |
1
2
3
4
5
6
>
Clinical Trials
Historical Success Rate
Phase 1
100%1/1
Phase 2
78%7/9
Phase 3
78%18/23
Approved: 12Overall Success rate: 61%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use